SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-029722
Filing Date
2020-10-02
Accepted
2020-10-02 06:04:32
Documents
13
Period of Report
2020-09-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea127714-8k_nektar.htm   iXBRL 8-K 21778
  Complete submission text file 0001213900-20-029722.txt   159874

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktr-20200928.xsd EX-101.SCH 3407
3 XBRL DEFINITION FILE nktr-20200928_def.xml EX-101.DEF 10693
4 XBRL LABEL FILE nktr-20200928_lab.xml EX-101.LAB 21586
5 XBRL PRESENTATION FILE nktr-20200928_pre.xml EX-101.PRE 11055
6 EXTRACTED XBRL INSTANCE DOCUMENT ea127714-8k_nektar_htm.xml XML 2473
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 201218007
SIC: 2834 Pharmaceutical Preparations